Funding for vaccine development
On 16 March, the European Commission offered up to €80 million of financial support to CureVac, a highly innovative vaccine developer from Tübingen, Germany, to scale up development and production of a vaccine against the Coronavirus in Europe.
Publication date: 08 April 2020